Nel (NEL) Q4 2016 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2016 earnings summary
17 Oct, 2026Executive summary
Q4 revenue reached NOK 50.6 million, up from NOK 24.4 million in Q3; FY 2016 revenue was NOK 114.5 million.
Commercial progress included hydrogen fueling and electrolyser contracts, the Kjørbo station opening, and plans for renewable hydrogen production in California.
Outlook emphasized growing hydrogen demand, increased H2Station® production in 2017, and development of integrated projects and renewable hydrogen solutions.
Financial highlights
FY 2016 operating revenue was NOK 114.5 million vs. NOK 118.2 million in 2015; Q4 revenue was NOK 50.6 million vs. NOK 35.6 million in Q4 2015.
FY EBITDA was NOK -44.9 million and EBIT NOK -55.3 million; excluding NOK 10.3 million of non-cash share incentive costs, EBITDA was NOK -34.6 million and EBIT NOK -45.1 million.
FY net loss was NOK 55.8 million, compared with NOK 12.7 million in 2015; pre-tax loss was NOK 62.6 million vs. NOK 16.1 million.
Q4 cash balance was NOK 225.5 million, up from NOK 223.6 million at Q3 end and down from NOK 313.0 million at Q4 2015 end.
Outlook and guidance
H2Station® production ramp-up planned for 2017; Herning facility development was on budget and schedule, with nameplate capacity of ~300 stations annually.
Rotolyser testing was planned for Q2 2017, with longer-duration tests in fall 2017 subject to design verification; target commercial launch was 2018 at 10 Nm³/h.
First SunPower-linked solar hydrogen plant targeted for H2 2017, with annual production capacity up to 120 metric tons and target sales price of $4/kg.
Iceland delivery of the first fueling station and electrolyser targeted toward end-2017; the network could expand alongside fuel-cell vehicle deployment.
Latest events from Nel
- Revenue grew 8% YoY as hydrogen orders expanded, while near-term EBITDA remained under pressure.NEL
Q4 2018 - Record backlog and mega-scale hydrogen projects put capacity expansion in focus.NEL
Q4 2017 - Order intake surged as revenue fell, Alkaline weakened and HYDS projects remained at risk.NEL
Q3 2026 - Order intake soared 224% as new technology launched, despite revenue and EBITDA declines.NEL
Q2 2026 - Revenue and orders fell, but EBITDA loss narrowed and new technology launches are underway.NEL
Q1 2026 - Order intake surged and new tech launch is set for 2026 despite heavy impairments and losses.NEL
Q4 2025 - Revenue down 10%, net loss narrowed, and major strategic deals followed Cavendish spin-off.NEL
Q2 2024 - Revenue fell 44% but record PEM order intake and cost cuts support strong cash reserves.NEL
Q1 2025 - Q4 2024 saw improved EBITDA, strong cash, and tech advances amid order and backlog shifts.NEL
Q4 2024